Direct evidence that hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells is mediated by urokinase

Journal of Hepatology

Volumn 30, Issue 3, 1999, Pages 511-518

  Monvoisin, Arnaud ^a   Neaud, Véronique ^a   Lédinghen, Victor De ^a   Dubuisson, Liliane ^a   Balabaud, Charles ^a   Bioulac Sage, Paulette ^a   Desmoulière, Alexis ^a   Rosenbaum, Jean ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Cancer; Hepatocyte growth factor; Invasion; Liver; Urokinase

Indexed keywords

MATRIGEL; SCATTER FACTOR; UROKINASE;

ARTICLE; CANCER INVASION; ENZYME INDUCTION; GLYCOSYLATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MEDIATOR RELEASE; MYOFIBROBLAST; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZYMOGRAPHY;

EID: 0032996954     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80113-5     Document Type: Article

References (35)

1. Enzan H, Himeno H, Iwamura S, Onishi S, Saibara T, Yamamoto Y, et al. α-smooth muscle actin positive perisinusoidal stromal cells in human hepatocellular carcinoma. Hepatology. 19:1994;895-903.
2. Neaud V, Faouzi S, Guirouilh J, Le Bail B, Balabaud C, Bioulac-Sage P, et al. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor. Hepatology. 26:1997;1458-1486.
3. Michalopoulos G, Houck KA, Dolan ML, Luetteke NC. Control of hepatocyte replication by two serum factors. Cancer Res. 44:1984;4414-4419.
4. Stoker M, Gherardi E, Perryman M, Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature. 327:1987;239-242.
5. Montesano R, Matsumoto K, Nakamura T, Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell. 67:1991;901-908.
6. Bottaro DP, Rubin JS, Faletto DL, Chan AML, Kmiecik TE, Vande Woude GF, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science. 251:1991;802-804.
7. Hasegawa Y, Yamamoto M, Maeda S, Saitoh Y. Hepatocyte growth factor and its receptor/c-MET regulate both cell growth and invasion of human pancreatic cancer. Int J Oncol. 7:1995;877-881.
8. Matsumoto K, Date K, Shimura H, Nakamura T. Acquisition of invasive phenotype in gallbadder cancer cells via mutual interaction of stromal fibroblasts and cancer cells as mediated by hepatocyte growth factor. Jpn J Cancer Res. 87:1996;702-710.
9. Jeffers M, Rong S, Vande Woude GF. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-Met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol. 16:1996;1115-1125.
10. Pepper MS, Matsumoto K, Nakamura T, Orci L, Montesano R. Hepatocyte growth factor increases urokinase-type plasminogen activator (μ-PA) and μ-PA receptor expression in Madin-Darby canine kidney epithelial cells. J Biol Chem. 267:1992;20493-20496.
11. Uchiyama A, Essner R, Doi F, Nguyen T, Ramming KP, Nakamura T, et al. Interleukin 4 inhibits hepatocyte growth factor-induced invasion and migration of colon carcinomas. J Cell Biochem. 62:1996;443-453.
12. Kasai S, Arimura H, Nishida M, Suyama T. Primary structure of single-chain pro-urokinase. J Biol Chem. 260:1985;12382-12389.
13. Roldan AL, Cubellis MV, Masucci MT, Behrendt N, Lund LR, Dano K, et al. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J. 9:1990;467-474.
14. Carmeliet P, Moons L, Dewerchin M, Rosenberg S, Herbert JM, Lupu F, et al. Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice. J Cell Biol. 140:1998;233-245.
15. Towle MJ, Lee A, Maduakor EC, Schwartz E, Bridges AJ, Littlefield BA. Inhibition of urokinase by 4-substituted benzo[b]-thiophene-2-carboxamidines: an important new class of selective synthetic urokinase inhibitors. Cancer Res. 53:1993;2553-2559.
16. Win KM, Charlotte F, Mallat A, Cherqui D, Martin N, Mavier P, et al. Mitogenic effect of TGFβ1 on human Ito cell in culture: evidence for mediation by endogenous platelet derived growth factor. Hepatology. 18:1993;137-145.
17. Blazejewski S, Préaux AM, Mallat A, Brochériou I, Mavier P, Dhumeaux D, et al. Human myofibroblast-like cells obtained by outgrowth are representative of the fibrogenic cells in the liver. Hepatology. 22:1995;788-797.
18. Pyke IC, Kristensen P, Ralfkiaer E, Grondahl-Hansen J, Eriksen J, Blasi F, et al. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am J Pathol. 138:1991;1059-1067.
19. Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem. 102:1980;344-352.
20. Stephens RW, Pöllänen J, Tapiovaara H, Leung KC, Sim PS, Salonen EM, et al. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants. J Cell Biol. 108:1989;1987-1995.
21. Lottenberg R, Christensen U, Jackson MC, Coleman PL. Assay of coagulation proteases using peptide chromogenic and fiuorogenic substrates. Methods Enzymol. 80:1981;341-381.
22. Pyke C, Eriksen J, Solberg H, Schnack Nielsen B, Kristensen P, Lund LR, et al. An alternatively spliced variant of mRNA for the human receptor for urokinase plasminogen activator. FEBS Lett. 326:1993;69-73.
23. Wojta J, Nakamura T, Fabry A, Hufnagl P, Beckmann R, McGrath K, et al. Hepatocyte growth factor stimulates expression of plasminogen activator inhibitor type 1 and tissue factor in HepG2 cells. Blood. 8:1994;151-157.
24. Cohen RL, Xi XP, Crowley CW, Lucas BK, Levinson AD, Shuman MA. Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumor cells. Blood. 78:1991;479-487.
25. Hollas W, Blasi F, Boyd D. Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer. Cancer Res. 51:1991;3690-3695.
26. Kamiyama T, Une Y, Uchino J, Hamada J. Hepatocyte growth factor enhances the invasion activity of human hepatocellular carcinoma cell lines. Int J Oncol. 12:1998;655-659.
27. Baramova EN, Bajou K, Remacle A, L'Hoir C, Krell HW, Weidle UH, et al. Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation. FEBS Lett. 405:1997;157-162.
28. Naldini L, Tamagnone L, Vigna E, Sachs M, Hartmann G, Birchmeier W, et al. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J. 11:1992;4825-4833.
29. Miyazawa K, Shimomura T, Kitamura A, Kondo J, Morimoto Y, Kitamura N. Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. J Biol Chem. 268:1993;10024-10028.
30. Keski-Oja J, Lohi J, Tuuttila A, Tryggvason K, Vartio T. Proteolytic processing of the 72 000-Da type IV collagenase by urokinase plasminogen activator. Exp Cell Res. 202:1992;471-476.
31. Abe T, Mori T, Kohno K, Seiki M, Hayakawa T, Welgus HG, et al. Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells. Clin Exp Metast. 12:1994;296-304.
32. Musso O, Théret N, Campion JP, Turlin B, Milani S, Grappone C, et al. In situ detection of matrix metalloproteinase-2 (MMP-2) and the metalloproteinase inhibitor TIMP2 transcripts in human primary hepatocellular carcinoma and in liver metastasis. J Hepatol. 26:1997;593-605.
33. Morita Y, Hayashi Y, Wang Y, Kanamaru T, Suzuki S, Kawasaki K, et al. Expression of urokinase-type plasminogen activator receptor in hepatocellular carcinoma. Hepatology. 25:1997;856-861.
34. Xing RH, Mazar A, Henkin J, Rabbani A. Prevention of breast cancer growth, invasion, and metastasis by antiestrogen tamoxifen alone or in combination with urokinase inhibitor B-428. Cancer Res. 57:1997;3585-3593.
35. Alonso DF, Farias EF, Ladeda V, Davel L, Puricelli L, Bal De Kier Joffé E. Effects of synthetic urokinase inhibitors on local invasion and metastasis in a murine mammary tumor model. Cancer Res. 40:1996;209-223.